Speaking of vaccines (and when are we not!): Our biotech reporter Andrew Dunn is moderating a conversation on October 5 at 2 p.m. ET on the coronavirus vaccine race with 3 top experts:
Maria Elena Bottazzi, co-director of Texas Children's Hospital Center for Vaccine Development
Art Caplan, bioethicist and founding head of the Division of Medical Ethics at New York University School of Medicine
Dr. William Haseltine, infectious-disease expert and chair and president of ACCESS Health International
Johnson & Johnson, the world's largest healthcare company, advanced its coronavirus vaccine candidate into the final stage of clinical trials on Wednesday.
J&J will recruit up to 60,000 volunteers from around the world, including in the US, South Africa, Brazil, Argentina, Columbia, and Chile, said Paul Stoffels, the pharma giant's chief scientific officer.
We could know as soon as next month if some of the leading coronavirus vaccine candidates work.
To help set expectations and understand what to look for as the results come in, Business Insider spoke with experts in virology, vaccine development, and infectious disease.
No comments